The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A racemate comprising equimolar amounts of (R)- and (S)-nafenopin. It is a peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an hypolipidemic agent.
[Nafenopin results in increased activity of PPARA protein] which results in increased expression of ACAA1 mRNA; [Nafenopin results in increased activity of PPARA protein] which results in increased expression of ACAA1 protein
[Nafenopin results in increased activity of PPARA protein] which results in increased expression of ACOX1 mRNA; [Nafenopin results in increased activity of PPARA protein] which results in increased expression of ACOX1 protein
Nafenopin results in increased expression of CAT protein [Nafenopin results in increased activity of PPARA protein] which results in increased expression of CAT protein
Nafenopin results in increased expression of CYP4A1 mRNA Okadaic Acid inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA]; tautomycin inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA]
[Nafenopin results in increased activity of PPARA protein] which results in increased expression of CYP4A6 mRNA; aroclor 1260 inhibits the reaction [Nafenopin results in increased activity of PPARA protein]; Okadaic Acid inhibits the reaction [Nafenopin results in increased activity of PPARA protein] Nafenopin results in decreased phosphorylation of PPARA protein Nafenopin results in increased activity of PPARA protein; Nafenopin results in increased activity of PPARA protein mutant form Nafenopin results in decreased expression of PPARA mRNA [Nafenopin results in increased activity of PPARA protein] which results in increased expression of ACAA1 mRNA; [Nafenopin results in increased activity of PPARA protein] which results in increased expression of ACAA1 protein; [Nafenopin results in increased activity of PPARA protein] which results in increased expression of ACOX1 mRNA; [Nafenopin results in increased activity of PPARA protein] which results in increased expression of ACOX1 protein; [Nafenopin results in increased activity of PPARA protein] which results in increased expression of CAT protein; [Nafenopin results in increased activity of PPARA protein] which results in increased expression of EHHADH mRNA; Okadaic Acid inhibits the reaction [Nafenopin results in decreased phosphorylation of PPARA protein]; Okadaic Acid inhibits the reaction [Nafenopin results in increased activity of PPARA protein mutant form]; Okadaic Acid inhibits the reaction [Nafenopin results in increased activity of PPARA protein] Nafenopin results in increased expression of PPARA protein